BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1029 related articles for article (PubMed ID: 15841457)

  • 1. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
    Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
    Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
    Stieger B
    Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
    Lepist EI; Gillies H; Smith W; Hao J; Hubert C; St Claire RL; Brouwer KR; Ray AS
    PLoS One; 2014; 9(1):e87548. PubMed ID: 24498134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
    Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
    Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic cholestasis, causes and consequences for hepatobiliary transport.
    Jansen PL; Sturm E
    Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver.
    Hagenbuch N; Reichel C; Stieger B; Cattori V; Fattinger KE; Landmann L; Meier PJ; Kullak-Ublick GA
    J Hepatol; 2001 Jun; 34(6):881-7. PubMed ID: 11451172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride.
    Geier A; Kim SK; Gerloff T; Dietrich CG; Lammert F; Karpen SJ; Stieger B; Meier PJ; Matern S; Gartung C
    J Hepatol; 2002 Aug; 37(2):198-205. PubMed ID: 12127424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin-induced injury in HepG2 cells is alleviated by TUDCA via increasing bile acid transporters expression and enhancing the Nrf2-mediated adaptive response.
    Zhang W; Chen L; Feng H; Wang W; Cai Y; Qi F; Tao X; Liu J; Shen Y; Ren X; Chen X; Xu J; Shen Y
    Free Radic Biol Med; 2017 Nov; 112():24-35. PubMed ID: 28688954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained repression and translocation of Ntcp and expression of Mrp4 for cholestasis after rat 90% partial hepatectomy.
    Miura T; Kimura N; Yamada T; Shimizu T; Nanashima N; Yamana D; Hakamada K; Tsuchida S
    J Hepatol; 2011 Aug; 55(2):407-14. PubMed ID: 21167233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of bile salt and organic anion transporters in developing rat liver.
    Gao B; St Pierre MV; Stieger B; Meier PJ
    J Hepatol; 2004 Aug; 41(2):201-8. PubMed ID: 15288467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
    Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
    Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of hepatic bile salt and organic anion transporters in pregnant and postpartum rats and the role of prolactin.
    Cao J; Huang L; Liu Y; Hoffman T; Stieger B; Meier PJ; Vore M
    Hepatology; 2001 Jan; 33(1):140-7. PubMed ID: 11124830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.
    Vanwijngaerden YM; Wauters J; Langouche L; Vander Perre S; Liddle C; Coulter S; Vanderborght S; Roskams T; Wilmer A; Van den Berghe G; Mesotten D
    Hepatology; 2011 Nov; 54(5):1741-52. PubMed ID: 21800341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
    Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
    Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal role of hepatic transporters in the hepatoprotection against LCA-induced intrahepatic cholestasis.
    Beilke LD; Besselsen DG; Cheng Q; Kulkarni S; Slitt AL; Cherrington NJ
    Toxicol Sci; 2008 Mar; 102(1):196-204. PubMed ID: 18032408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatobiliary transporter expression and post-operative jaundice in patients undergoing partial hepatectomy.
    Bernhardt GA; Zollner G; Cerwenka H; Kornprat P; Fickert P; Bacher H; Werkgartner G; Müller G; Zatloukal K; Mischinger HJ; Trauner M
    Liver Int; 2012 Jan; 32(1):119-27. PubMed ID: 22098322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive familial intrahepatic cholestasis.
    Jacquemin E
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.
    Shoda J; Kano M; Oda K; Kamiya J; Nimura Y; Suzuki H; Sugiyama Y; Miyazaki H; Todoroki T; Stengelin S; Kramer W; Matsuzaki Y; Tanaka N
    Am J Gastroenterol; 2001 Dec; 96(12):3368-78. PubMed ID: 11774951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.
    Zollner G; Fickert P; Silbert D; Fuchsbichler A; Marschall HU; Zatloukal K; Denk H; Trauner M
    J Hepatol; 2003 Jun; 38(6):717-27. PubMed ID: 12763363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.